Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Tolerability and Safety Study of a Powdered Human Milk-based Breastmilk Fortifier (Neokare) in Neonates With Gastrointestinal Problems

NCT05293353 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.

NCT NCT05293353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Tolerability and Safety Study of a Powdered Human Milk-based Breastmilk Fortifier (Neokare) in Neonates With Gastrointestinal Problems
Lead sponsor
University Hospital Southampton NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
June 9, 2022
Completion date
June 30, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorectal malformations, atresia, intestinal, cows milk allergy, exomphalos, gastroschisis, hirschsprung disease, intestinal perforation, meconium ileus, nec, preterm, volvulus